RPG LIFE SCIENCES = Q2 FY 2011 (SEP 2010) RESULT = IMPROVING = MORE NEW PRODUCTS MAY BOOST SALES

RPG Life Sciences Limited

NSE Symbol   RPGLIFE

RPG Life Sciences is improving gradually in its performance as can be seen from the table below:

Net Sales at Rs.50.66 cr is – up by 33.88% over previous Qtr and by 22.28% over corresponding Qtr.

Net Profit is Rs.3.91 cr – up by 6.54% from previous Qtr and by 39.64% from corresponding Qtr.

Basic EPS  is Rs.2.6 (Face value : Rs.8) – against Rs.2.43 of  previous qtr and Rs.1.95 of corresponding Qtr. The annual EPS is likely to be over Rs.10.

Its MP is Rs.108. Thus, PE Ratio 10.RPG is improving its R&D effort and launching biotech products .Hopefully, its sales will be improving each quarter.

RPG LIFE	30-Sep-10	30-Jun-10	DIF% 1	30-Sep-09	DIF% 2
Net Sales	5066	3784	33.88	4143	22.28
Other Operatg Income	72	119	-39.5	57	26.32
Increase/decrease in SIT & WIP	-137	-198	-30.81	-57	140.35
Raw Materials	1203	908	32.49	1033	16.46
Purchase of Traded Goods	330	225	46.67	171	92.98
Employees Cost	1147	796	44.1	813	41.08
Depreciation	238	228	4.39	229	3.93
Other Expenditure	1664	1291	28.89	1432	16.2
Total Expenditure	4445	3250	36.77	3621	22.76
Profit from Operations	693	653	6.13	579	19.69
Other Income	1	1	0	2	-50
Interest	146	149	-2.01	207	-29.47
Profit before tax	548	505	8.51	374	46.52
Tax expense	157	138	13.77	94	67.02
Net Profit  after tax	391	367	6.54	280	39.64
Net Profit	391	367	6.54	280	39.64
Dividend (%)	-	-		-
Face Value (In Rs	8	8	0	8	0
Paid Up Equity	1321	1206	9.54	1150	14.87
Basic EPS	2.6	2.43	7	1.95	33.33
Diluted EPS	2.37	2.22	6.76	1.7	39.41
Public holding (%)	49	53.67	-8.7	56.29	-12.95

 *  *  *    E  N  D   *  *  *